chlorpromazine has been researched along with loxapine in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 23 (54.76) | 18.7374 |
1990's | 2 (4.76) | 18.2507 |
2000's | 12 (28.57) | 29.6817 |
2010's | 5 (11.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choudhary, MS; Craigo, SC; Meltzer, HY; Monsma, FJ; Roth, BL; Shen, Y; Sibley, DR; Uluer, A | 1 |
Druck, T; Hamblin, MW; Huebner, K; Khan, N; Kohen, R; Lachowicz, JE; Meltzer, HY; Metcalf, MA; Roth, BL; Sibley, DR | 1 |
Strassburg, CP; Tukey, RH | 1 |
Grinde, E; Herrick-Davis, K; Teitler, M | 1 |
Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S | 1 |
McKinnon, RA; Miners, JO; Smith, PA; Sorich, MJ | 1 |
Glennon, RA | 1 |
Andaluz, B; Buschmann, H; Codony, X; Cubí, R; Díaz, JL; Dordal, A; Guitart, X; Hernández, E; Hernández, S; Holenz, J; Mas, J; Mercè, R; Monroy, X; Pérez, R; Romero, G; Sánchez, E; Sanfeliu, O; Torrens, A | 1 |
Herrick-Davis, K; Purohit, A; Smith, C; Teitler, M | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bishop, MP; Dunnett, CW; Kiltie, H; Simpson, GM | 1 |
Avery, GS; Brogden, RN; Heel, RC; Speight, TM | 1 |
Coupet, J; Rauh, CE | 1 |
Davis, JM | 1 |
Moore, DF | 1 |
Dube, KC; Kumar, N | 1 |
Davis, CM; Fenimore, DC; Meyer, CJ | 1 |
Haher, J; Simpson, GM; Varga, E | 1 |
Schiele, BC | 1 |
Asper, H; Bürki, HR; Ruch, W; Sayers, AC | 1 |
Matsubara, S; Meltzer, HY | 1 |
Andree, TH; Koenig, JI; Meltzer, HY; Mikuni, M; Tong, CY | 1 |
Ricketts, JE; Zisook, S | 1 |
Escobar, JI; Tuason, VB | 1 |
Michael, RP; Schaefer, GJ | 1 |
Dahl, SG | 1 |
Davis, KL; Kendler, KS | 1 |
Escobar, JI; Garvey, M; Schiele, B; Tuason, VB | 1 |
Kane, J; Rieder, E; Rifkin, A; Saraf, K; Sarantakos, S | 1 |
Leone, NF | 1 |
Einarson, TR; Ewing, DG | 1 |
Goudie, AJ; Smith, JA | 1 |
Gabryel, B; Herman, ZS; Kowalski, J; Labuzek, K | 1 |
Burdock, EI; Gershon, S; Hardesty, AS; Linden, KJ | 1 |
Chaaban, R; Collet, F; Lemyze, M | 1 |
Eichelman, BS; Hutchins, LG; Kornguth, ML | 1 |
Lam, D; Patten, SB; Pringsheim, T; Tano, DS | 1 |
6 review(s) available for chlorpromazine and loxapine
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Chlorpromazine; Dibenzoxazepines; Drug Interactions; Haloperidol; Humans; Intestinal Absorption; Kinetics; Loxapine; Receptors, Dopamine; Schizophrenia; Thiothixene; Trifluoperazine | 1978 |
Active metabolites of neuroleptic drugs: possible contribution to therapeutic and toxic effects.
Topics: Antipsychotic Agents; Biotransformation; Brain; Chlorpromazine; Erythrocytes; Humans; Loxapine; Methotrimeprazine; Thioridazine | 1982 |
8 trial(s) available for chlorpromazine and loxapine
Article | Year |
---|---|
Efficacy of loxapine in the treatment of paranoid schizophrenia.
Topics: Adult; Brief Psychiatric Rating Scale; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Drug Administration Schedule; Drug Evaluation; Female; Humans; Loxapine; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid; Trifluoperazine | 1977 |
Recent developments in the drug treatment of schizophrenia.
Topics: Chlorpromazine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance; Fluphenazine; Humans; Loxapine; Molindone; Phenothiazines; Placebos; Promazine; Research Design; Schizophrenia; Structure-Activity Relationship; Tranquilizing Agents; Trifluoperazine | 1976 |
Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
Topics: Acute Disease; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Female; Humans; Loxapine; Male; Psychiatric Status Rating Scales; Schizophrenia | 1975 |
Loxapine succinate: a comparative study with chlorpromazine.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Humans; Loxapine; Male; Mental Status Schedule; Middle Aged; Psychotic Disorders; Time Factors | 1976 |
Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
Topics: Adult; Aged; Amobarbital; Analysis of Variance; Chemical Phenomena; Chemistry; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Drug Evaluation; Humans; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenia, Paranoid | 1975 |
Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
Topics: Adult; Basal Ganglia Diseases; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Dizziness; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Hospitalization; Humans; Hypotension, Orthostatic; Loxapine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia, Paranoid | 1984 |
Is loxapine more effective than chlorpromazine in paranoid schizophrenia?
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Female; Hospitalization; Humans; Loxapine; Male; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia, Paranoid | 1984 |
Response of borderline patients to loxapine and chlorpromazine.
Topics: Adolescent; Adult; Borderline Personality Disorder; Chlorpromazine; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Female; Humans; Loxapine; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales | 1982 |
28 other study(ies) available for chlorpromazine and loxapine
Article | Year |
---|---|
Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
Topics: Animals; Antipsychotic Agents; Cell Line; Molecular Structure; Rats; Receptors, Serotonin | 1994 |
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line, Transformed; Chlorocebus aethiops; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Clozapine; DNA, Complementary; Genes; Humans; Kinetics; Molecular Sequence Data; Open Reading Frames; Protein Conformation; Rats; Receptors, Serotonin; Recombinant Proteins; Sequence Alignment; Sequence Homology, Nucleic Acid; Serotonin Agents; Signal Transduction; Species Specificity | 1996 |
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
Topics: Animals; Antipsychotic Agents; COS Cells; Dose-Response Relationship, Drug; Humans; Inositol Phosphates; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Receptor Agonists | 2000 |
H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Discriminant Analysis; Drug Evaluation, Preclinical; Forecasting; Humans; Protein Binding; Receptors, Histamine H1; Statistics, Nonparametric; Weight Gain | 2003 |
Pharmacophore and quantitative structure-activity relationship modeling: complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity.
Topics: Catalysis; Glucuronides; Glucuronosyltransferase; Humans; Isoenzymes; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Substrate Specificity | 2003 |
Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
Topics: Adenylyl Cyclases; Benzoxazines; Cell Line; Humans; Indoles; Ligands; Piperidines; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Sulfonamides | 2005 |
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
Topics: Amino Acid Substitution; Antipsychotic Agents; Cell Line; Cyclic AMP; Humans; Mutagenesis, Site-Directed; Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 2005 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
Topics: Animals; Butyrophenones; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzoxazepines; Haloperidol; Hydroxylation; In Vitro Techniques; Loxapine; Membranes; Rats; Receptors, Dopamine; Spiperone | 1979 |
Improved gas chromatographic analysis of chlorpromazine in blood serum.
Topics: Chlorpromazine; Chromatography, Gas; Drug Interactions; Drug Stability; Humans; Loxapine; Promazine; Tranquilizing Agents | 1977 |
Psychotic exacerbations produced by neuroleptics.
Topics: Acute Disease; Antiparkinson Agents; Chlorpromazine; Humans; Loxapine; Psychoses, Substance-Induced; Tranquilizing Agents | 1976 |
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; Disease Models, Animal; Dopamine; Drug Tolerance; Female; Haloperidol; Homovanillic Acid; Humans; Loxapine; Male; Movement Disorders; Rats; Receptors, Drug; Stereotyped Behavior; Substance Withdrawal Syndrome | 1975 |
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Butyrophenones; Cerebral Cortex; Chlorpromazine; Clozapine; Dibenzazepines; Dibenzothiazepines; Down-Regulation; Flupenthixol; Kinetics; Loxapine; Male; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Serotonin; Spiro Compounds; Time Factors | 1989 |
Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex.
Topics: 5,7-Dihydroxytryptamine; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Female; Haloperidol; Imipramine; Ketanserin; Loxapine; Male; Piperidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Spiperone; Sulpiride | 1986 |
Psychopharmacologic approaches to the borderline patient.
Topics: Adult; Amphetamines; Antipsychotic Agents; Borderline Personality Disorder; Chlorpromazine; Female; Humans; Lithium; Loxapine; Monoamine Oxidase Inhibitors; Personality Disorders; Psychotropic Drugs | 1988 |
How effective is loxapine?
Topics: Chlorpromazine; Depression; Dibenzoxazepines; Humans; Loxapine; Psychiatric Status Rating Scales; Schizophrenia, Paranoid | 1986 |
Acute effects of neuroleptics on brain self-stimulation thresholds in rats.
Topics: Animals; Antipsychotic Agents; Brain; Chlorpromazine; Clozapine; Haloperidol; Loxapine; Male; Pimozide; Rats; Self Stimulation | 1980 |
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Chlorpromazine; Fluphenazine; Haloperidol; Homovanillic Acid; Loxapine; Male; Metoclopramide; Molindone; Phenylacetates; Rats; Rats, Inbred Strains; Sulpiride | 1984 |
Loxapine as an alternative to phenothiazines in a case of oculocutaneous skin pigmentation.
Topics: Chlorpromazine; Chronic Disease; Dibenzoxazepines; Eye Color; Humans; Loxapine; Male; Middle Aged; Photosensitivity Disorders; Schizophrenia; Skin Pigmentation | 1981 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
Chlorpromazine and loxapine reduce interleukin-1beta and interleukin-2 release by rat mixed glial and microglial cell cultures.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Cells, Cultured; Cerebral Cortex; Chlorpromazine; Dopamine Agonists; Dose-Response Relationship, Drug; Interleukin-1; Interleukin-2; Loxapine; Neuroglia; Quinpirole; Rats; Rats, Wistar; Time Factors | 2005 |
Problems and profits of cross-national collaborative studies.
Topics: Acute Disease; Antipsychotic Agents; Chlorpromazine; Controlled Clinical Trials as Topic; Feasibility Studies; Germany, West; Humans; Internationality; Loxapine; Multicenter Studies as Topic; Pilot Projects; Research Design; Schizophrenia; Switzerland; United States | 1974 |
Psychotic woman with painful abdominal distension. Life-threatening psychotropic drug-induced gastrointestinal hypomotility.
Topics: Abdomen, Acute; Antipsychotic Agents; Chlorpromazine; Cholinergic Antagonists; Critical Illness; Digestive System Surgical Procedures; Drug Therapy, Combination; Emergency Service, Hospital; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Intestinal Pseudo-Obstruction; Loxapine; Magnetic Resonance Imaging; Middle Aged; Psychotic Disorders; Risk Assessment; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Binding of psychotropic drugs to isolated alpha-acid glycoprotein.
Topics: Binding, Competitive; Chlorpromazine; Fluphenazine; Humans; Imipramine; Kinetics; Loxapine; Molindone; Orosomucoid; Protein Binding; Psychotropic Drugs; Thioridazine; Thiothixene; Trihexyphenidyl | 1981 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Female; Flupenthixol; Humans; Loxapine; Male; Olanzapine; Pharmacoepidemiology; Schizophrenia | 2011 |